Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

ClinicalTrials.gov ID: NCT00322257

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00322257. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 9:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in the United States of America (USA) and Canada. The aim of this research is to compare the efficacy (reduction in HbA1c and blood glucose) and pulmonary safety (pulmonary function, chest x-rays) of mealtime inhaled insulin with subcutaneous insulin aspart both in combination with insulin determir in Type 1 Diabetes.

Study identification

NCT ID
NCT00322257
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
596 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2006 (Actual)
Primary completion
Apr 2, 2008 (Actual)
Completion
Apr 2, 2008 (Actual)
Last update posted
Sep 5, 2018

2006 – 2008

United States locations

U.S. sites
86
U.S. states
34
U.S. cities
81
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35294 —
Novo Nordisk Investigational Site Tuscaloosa Alabama 35406 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Encino California 91436 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Inglewood California 90301 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site Mission Viejo California 92691 —
Novo Nordisk Investigational Site Poway California 92064 —
Novo Nordisk Investigational Site San Mateo California 94401 —
Novo Nordisk Investigational Site Santa Barbara California 93105 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Vista California 92084 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Aurora Colorado 80045 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80909 —
Novo Nordisk Investigational Site New Britain Connecticut 06050 —
Novo Nordisk Investigational Site Norwalk Connecticut 06851 —
Novo Nordisk Investigational Site Waterbury Connecticut 06708 —
Novo Nordisk Investigational Site Boca Raton Florida 33433 —
Novo Nordisk Investigational Site Hollywood Florida 33021 —
Novo Nordisk Investigational Site Lake Mary Florida 32746 —
Novo Nordisk Investigational Site Melbourne Florida 32901 —
Novo Nordisk Investigational Site Merritt Island Florida 32953 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site West Palm Beach Florida 33401 —
Novo Nordisk Investigational Site Athens Georgia 30606 —
Novo Nordisk Investigational Site Atlanta Georgia 30318 —
Novo Nordisk Investigational Site Savannah Georgia 31406 —
Novo Nordisk Investigational Site Honolulu Hawaii 96813 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Peoria Illinois 61615 —
Novo Nordisk Investigational Site Springfield Illinois 62711 —
Novo Nordisk Investigational Site Lafayette Indiana 47904 —
Novo Nordisk Investigational Site New Albany Indiana 47150 —
Novo Nordisk Investigational Site Des Moines Iowa 50314 —
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808 —
Novo Nordisk Investigational Site Scarborough Maine 04074 —
Novo Nordisk Investigational Site Hyattsville Maryland 20782 —
Novo Nordisk Investigational Site Springfield Massachusetts 01199 —
Novo Nordisk Investigational Site Waltham Massachusetts 02453 —
Novo Nordisk Investigational Site Bloomington Minnesota 55420 —
Novo Nordisk Investigational Site Duluth Minnesota 55805 —
Novo Nordisk Investigational Site Minneapolis Minnesota 55416-2699 —
Novo Nordisk Investigational Site Tupelo Mississippi 38801 —
Novo Nordisk Investigational Site Jefferson City Missouri 65109 —
Novo Nordisk Investigational Site Kansas City Missouri 64114 —
Novo Nordisk Investigational Site St Louis Missouri 63141 —
Novo Nordisk Investigational Site Butte Montana 59701 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Dover New Hampshire 03820 —
Novo Nordisk Investigational Site Hampton New Hampshire 03842 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site Albany New York 12206 —
Novo Nordisk Investigational Site New Hyde Park New York 11042 —
Novo Nordisk Investigational Site Rochester New York 14642 —
Novo Nordisk Investigational Site Asheville North Carolina 28803 —
Novo Nordisk Investigational Site Greenville North Carolina 27834 —
Novo Nordisk Investigational Site Cincinnati Ohio 45267 —
Novo Nordisk Investigational Site Cleveland Ohio 44122 —
Novo Nordisk Investigational Site Dayton Ohio 45406 —
Novo Nordisk Investigational Site Kettering Ohio 45429 —
Novo Nordisk Investigational Site Mentor Ohio 44060 —
Novo Nordisk Investigational Site Medford Oregon 97504 —
Novo Nordisk Investigational Site Hershey Pennsylvania 17033 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Dallas Texas 75390-8858 —
Novo Nordisk Investigational Site Midland Texas 79707 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site Ogden Utah 84403 —
Novo Nordisk Investigational Site Olympia Washington 98502 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Spokane Washington 99208 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00322257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 5, 2018 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.